This is a Validated Antibody Database (VAD) review about mouse LFA 1, based on 73 published articles (read how Labome selects the articles), using LFA 1 antibody in all methods. It is aimed to help Labome visitors find the most suited LFA 1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
LFA 1 synonym: (p180); Cd11a; LFA-1; LFA-1A; Ly-15; Ly-21

Invitrogen
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 2b
Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples (fig 2b). Front Immunol (2018) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 1c
Invitrogen LFA 1 antibody (Thermofisher, M17/4) was used in flow cytometry on mouse samples (fig 1c). J Leukoc Biol (2019) ncbi
mouse monoclonal (TS1/22)
  • western blot; human; fig s2b
Invitrogen LFA 1 antibody (ThermoFisher, MA11A10) was used in western blot on human samples (fig s2b). EMBO Rep (2018) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; 1:200; loading ...; fig 3a
Invitrogen LFA 1 antibody (Affymetrix/eBioscience, M17/4) was used in flow cytometry on mouse samples at 1:200 (fig 3a). J Clin Invest (2018) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig s1f
Invitrogen LFA 1 antibody (eBioscience, 11-0111-81) was used in flow cytometry on mouse samples (fig s1f). Immunity (2017) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 3d
Invitrogen LFA 1 antibody (eBiosciences, M17/4) was used in flow cytometry on mouse samples (fig 3d). J Cell Biol (2017) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig e3a
In order to investigate the function of SLAMF in phagocytosis of haematopoietic tumour cells, Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples (fig e3a). Nature (2017) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig s1b
In order to study the effects of IL-10R signaling during Plasmodium berghei ANKA-induced experimental cerebral malaria, Invitrogen LFA 1 antibody (eBiosciences, M17/4) was used in flow cytometry on mouse samples (fig s1b). Infect Immun (2017) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse; loading ...; fig 7
In order to explore if the binding strength of a peptide for a MHC is a critical factor to determine the duration of pMHC-mediated T cell activation, Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in blocking or activating experiments on mouse samples (fig 7). Mol Cells (2017) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 6d
In order to discover structural elements that distinguish Grp94 from Hsp90, Invitrogen LFA 1 antibody (eBioscience, M174) was used in flow cytometry on mouse samples (fig 6d). PLoS ONE (2016) ncbi
mouse monoclonal (TS1/22)
  • blocking or activating experiments; human; loading ...; fig 5c
In order to determine the contribution of CD16 positive monocytes to antibody-dependent cellular cytotoxicity, Invitrogen LFA 1 antibody (Thermo Scientific, TS1/22) was used in blocking or activating experiments on human samples (fig 5c). Sci Rep (2016) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 7a
In order to investigate the contribution of TGF-beta to the eomesodermin-driven CD4 T cell program during viral infection, Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples (fig 7a). J Clin Invest (2016) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 8a
In order to determine the function of the SLAM family of proteins in natural killer cells, Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples (fig 8a). J Exp Med (2016) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 2a
In order to demonstrate that Blimp-1 controls CD4 T cell exhaustion, Invitrogen LFA 1 antibody (Affymetrix eBioscience, M17/4) was used in flow cytometry on mouse samples (fig 2a). J Exp Med (2016) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse; fig 8
Invitrogen LFA 1 antibody (eBioscience, 16-0111) was used in blocking or activating experiments on mouse samples (fig 8). Nat Commun (2016) ncbi
mouse monoclonal (TS1/22)
  • blocking or activating experiments; human; 10 ug/ml; loading ...; fig 3b
In order to report that LFA-1 and Mac-1 on leukocytes bind to thrombomodulin, Invitrogen LFA 1 antibody (Thermo scientific, TS1/22) was used in blocking or activating experiments on human samples at 10 ug/ml (fig 3b). Biochem Biophys Res Commun (2016) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; 1:150; fig s4
In order to assess the role of NLRC5 to NK-T-cell crosstalk, Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples at 1:150 (fig s4). Nat Commun (2016) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 2
Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples (fig 2). J Immunol (2016) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 3
In order to study how DNAM-1 controls NK cell-mediated cytotoxicity and cytokine production, Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples (fig 3). J Exp Med (2015) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; 1:500
Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples at 1:500. Cell Res (2015) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 2
Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples (fig 2). J Immunol (2015) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 5d
In order to investigate the effect of IL-7 and anti-PD-1 treatment in sepsis model followed by Candida albicans infection, Invitrogen LFA 1 antibody (eBioscience, 11-0111-85) was used in flow cytometry on mouse samples (fig 5d). Shock (2015) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 2
  • immunocytochemistry; mouse; fig 2
Invitrogen LFA 1 antibody (Ebioscience, M17/4) was used in flow cytometry on mouse samples (fig 2) and in immunocytochemistry on mouse samples (fig 2). Immunol Cell Biol (2015) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; 1:100
In order to study the involvement of endothelium in efficient Treg T cell recruitment in vivo, Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples at 1:100. Nat Commun (2014) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse
Invitrogen LFA 1 antibody (eBioscience, M17/4) was used in flow cytometry on mouse samples . J Immunol (2014) ncbi
mouse monoclonal (TS1/22)
  • flow cytometry; human; fig 2
In order to identify ADP-ribosylation factor-like 8b as a factor required for natural killer cell-mediated cytotoxicity, Invitrogen LFA 1 antibody (Thermo Scientific, TS1/22) was used in flow cytometry on human samples (fig 2). Mol Biol Cell (2013) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 1
In order to investigate the effect of Stat6 in T cell expansion, survival, and recruitment to the lung, Invitrogen LFA 1 antibody (Caltag, M17/4) was used in flow cytometry on mouse samples (fig 1). J Immunol (2008) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse
In order to evaluate the use of biodegradable poly(D,L-lactic-co-glycolic acid) nanoparticles as a vaccine delivery system, Invitrogen LFA 1 antibody (E-Bioscience, M17/4) was used in flow cytometry on mouse samples . J Biomed Mater Res A (2007) ncbi
BioLegend
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig s3a
BioLegend LFA 1 antibody (BioLegend, M17/4) was used in flow cytometry on mouse samples (fig s3a). Sci Adv (2020) ncbi
mouse monoclonal (m24)
  • immunocytochemistry; human; 1:40; fig 2h
BioLegend LFA 1 antibody (Biolegend, 363412) was used in immunocytochemistry on human samples at 1:40 (fig 2h). elife (2019) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 3f
BioLegend LFA 1 antibody (BioLegend, M17/4) was used in flow cytometry on mouse samples (fig 3f). J Immunol (2019) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse; 10 ug/ml; loading ...; fig 6b
BioLegend LFA 1 antibody (Biolegend, 101109) was used in blocking or activating experiments on mouse samples at 10 ug/ml (fig 6b). Cell Rep (2018) ncbi
mouse monoclonal (m24)
  • flow cytometry; human; loading ...; fig 4s1
BioLegend LFA 1 antibody (BioLegend, 363410) was used in flow cytometry on human samples (fig 4s1). elife (2018) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse; loading ...; fig 2e
BioLegend LFA 1 antibody (BioLegend, 101118) was used in blocking or activating experiments on mouse samples (fig 2e). Nat Commun (2018) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; loading ...; fig 1a
BioLegend LFA 1 antibody (BioLegend, M17/4) was used in flow cytometry on mouse samples (fig 1a). J Immunol (2018) ncbi
rat monoclonal (H155-78)
  • flow cytometry; mouse; loading ...; fig 6a
BioLegend LFA 1 antibody (Biolegend, 141011) was used in flow cytometry on mouse samples (fig 6a). J Immunol (2018) ncbi
rat monoclonal (H155-78)
  • flow cytometry; mouse; loading ...; fig s1f
BioLegend LFA 1 antibody (BioLegend, H155-78) was used in flow cytometry on mouse samples (fig s1f). J Exp Med (2017) ncbi
mouse monoclonal (m24)
  • immunocytochemistry; human; loading ...; fig 7b
BioLegend LFA 1 antibody (BioLegend, M24) was used in immunocytochemistry on human samples (fig 7b). J Cell Biol (2016) ncbi
rat monoclonal (H155-78)
BioLegend LFA 1 antibody (BioLegend, H155-78) was used . J Exp Med (2016) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse
BioLegend LFA 1 antibody (BioLegend, M17/4) was used in flow cytometry on mouse samples . Nature (2016) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse; loading ...
In order to study the contribution of p53-induced inflammation to heart failure, BioLegend LFA 1 antibody (BioLegend, 101115) was used in blocking or activating experiments on mouse samples . J Mol Cell Cardiol (2015) ncbi
mouse monoclonal (m24)
  • flow cytometry; human; loading ...; fig 4a
In order to look at patterns of S. Typhi-specific modulation of the homing potential of circulating Treg in patients with typhoid compared to healthy individuals, BioLegend LFA 1 antibody (biolegend, 363403) was used in flow cytometry on human samples (fig 4a). PLoS Pathog (2015) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse
  • flow cytometry; mouse
BioLegend LFA 1 antibody (Biolegend, M17/4) was used in blocking or activating experiments on mouse samples and in flow cytometry on mouse samples . Sci Rep (2015) ncbi
rat monoclonal (M17/4)
  • flow cytometry; mouse; fig 5
In order to determine the role of interferon regulatory factor 7 in Plasmodium berghei ANKA infection, BioLegend LFA 1 antibody (BioLegend, M17/4) was used in flow cytometry on mouse samples (fig 5). Eur J Immunol (2015) ncbi
rat monoclonal (H155-78)
  • immunocytochemistry; mouse; fig 1
In order to examine the role of the immunological synapse in T cell activation, BioLegend LFA 1 antibody (BioLegend, H155) was used in immunocytochemistry on mouse samples (fig 1). Immunol Cell Biol (2015) ncbi
rat monoclonal (M17/4)
BioLegend LFA 1 antibody (Biolegend, M17/4) was used . J Immunol Methods (2014) ncbi
rat monoclonal (H155-78)
  • flow cytometry; mouse
BioLegend LFA 1 antibody (BioLegend, 141005) was used in flow cytometry on mouse samples . Ann Neurol (2014) ncbi
rat monoclonal (H155-78)
BioLegend LFA 1 antibody (Biolegend, H155-78) was used . PLoS Pathog (2014) ncbi
Bio X Cell
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse; loading ...; fig 1d
Bio X Cell LFA 1 antibody (BioXcell, M17/4) was used in blocking or activating experiments on mouse samples (fig 1d). J Exp Med (2017) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse; loading ...; fig s5a
In order to show that parasite-specific CD8 positive T cell-induced fatal vascular breakdown and subsequent neuronal death in an animal model of cerebral malaria, Bio X Cell LFA 1 antibody (BioXcell, M17/4) was used in blocking or activating experiments on mouse samples (fig s5a). PLoS Pathog (2016) ncbi
BD Biosciences
rat monoclonal (2D7)
  • flow cytometry; mouse; loading ...; fig s6d
BD Biosciences LFA 1 antibody (BD Biosciences, 2D7) was used in flow cytometry on mouse samples (fig s6d). Science (2018) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; loading ...; fig 3a
BD Biosciences LFA 1 antibody (BD Horizon, 2D7) was used in flow cytometry on human samples (fig 3a). J Clin Invest (2019) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; loading ...; fig 1a
BD Biosciences LFA 1 antibody (BD Pharmigen, 2D7) was used in flow cytometry on human samples (fig 1a). Arthritis Res Ther (2018) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse; loading ...; fig 3a
BD Biosciences LFA 1 antibody (biosciences, 2D7) was used in flow cytometry on mouse samples (fig 3a). J Virol (2018) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; loading ...; fig 2d
BD Biosciences LFA 1 antibody (BD, 2D7) was used in flow cytometry on human samples (fig 2d). Ann Rheum Dis (2018) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; loading ...; fig st1
BD Biosciences LFA 1 antibody (BD, 2D7) was used in flow cytometry on human samples (fig st1). J Exp Med (2017) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; tbl 1
In order to compare methods of isolating skin mononuclear phagocytes, BD Biosciences LFA 1 antibody (Becton Dickinson, 2D7) was used in flow cytometry on human samples (tbl 1). J Leukoc Biol (2017) ncbi
rat monoclonal (2D7)
  • flow cytometry; human
In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, BD Biosciences LFA 1 antibody (BD BIOSCIENCES, 2D7) was used in flow cytometry on human samples . Nature (2017) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; loading ...; fig 4b
In order to compare the effect of CXCL4 and its variant CXCL4L1 on the differentiation of monocytes into macrophages and into immature monocyte-derived dendritic cells, BD Biosciences LFA 1 antibody (BD Biosciences, 2D7) was used in flow cytometry on human samples (fig 4b). PLoS ONE (2016) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse; fig 7
BD Biosciences LFA 1 antibody (BD Pharmingen, 2D7) was used in flow cytometry on mouse samples (fig 7). PLoS ONE (2016) ncbi
rat monoclonal (M17/4)
  • blocking or activating experiments; mouse
In order to compare extravasation of activated CD4+ and CD8+ T cells across primary mouse brain microvascular endothelial cells, BD Biosciences LFA 1 antibody (BD Pharmingen, 553337) was used in blocking or activating experiments on mouse samples . Eur J Immunol (2016) ncbi
rat monoclonal (2D7)
  • blocking or activating experiments; mouse; fig 8
BD Biosciences LFA 1 antibody (BD, 553118) was used in blocking or activating experiments on mouse samples (fig 8). Nat Commun (2016) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; fig 1b
In order to find predictive markers for patients that will develop gastrointestinal graft-versus-host-disease, BD Biosciences LFA 1 antibody (BD Biosciences, 2D7) was used in flow cytometry on human samples (fig 1b). JCI Insight (2016) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse; loading ...; fig s2a
In order to ask if T-bet regulates other T regulatory cell functions after entering the inflammatory site, BD Biosciences LFA 1 antibody (BD PharMingen, 2D7) was used in flow cytometry on mouse samples (fig s2a). J Immunol (2016) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse; loading ...; tbl s6
In order to characterize and determine the origin of arterial macrophages, BD Biosciences LFA 1 antibody (BD, 553120) was used in flow cytometry on mouse samples (tbl s6). Nat Immunol (2016) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse; fig 4
BD Biosciences LFA 1 antibody (BD, 562809) was used in flow cytometry on mouse samples (fig 4). Aging Cell (2016) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse; 1:100; fig s3
BD Biosciences LFA 1 antibody (BD Biosciences, 558191) was used in flow cytometry on mouse samples at 1:100 (fig s3). Nat Commun (2015) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; loading ...; fig 5e
In order to elucidate Th17 cell polarization, depletion, and restoration in response to HIV infection and antiretroviral therapy, BD Biosciences LFA 1 antibody (BD Pharmingen, 2D7) was used in flow cytometry on human samples (fig 5e). Retrovirology (2015) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse; 1:100
In order to assess the role of CDH17 in the long-term survival of memory B cells in the bone marrow, BD Biosciences LFA 1 antibody (BD Pharmingen, 557365) was used in flow cytometry on mouse samples at 1:100. PLoS ONE (2015) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse
BD Biosciences LFA 1 antibody (BD Biosciences, 2D7) was used in flow cytometry on mouse samples . J Leukoc Biol (2015) ncbi
rat monoclonal (2D7)
  • flow cytometry; human
BD Biosciences LFA 1 antibody (BD Biosciences, 2D7) was used in flow cytometry on human samples . J Immunol (2014) ncbi
rat monoclonal (2D7)
  • flow cytometry; mouse
BD Biosciences LFA 1 antibody (BD Biosciences, 2D7) was used in flow cytometry on mouse samples . Blood (2014) ncbi
rat monoclonal (2D7)
  • flow cytometry; human; loading ...
In order to correlate biomarkers associated with coagulation, monocyte activation, and inflammation in elite controllers of HIV infection, BD Biosciences LFA 1 antibody (BD Bioscience, 2D7) was used in flow cytometry on human samples . J Infect Dis (2014) ncbi
rat monoclonal (2D7)
  • flow cytometry; human
BD Biosciences LFA 1 antibody (BD Biosciences, 2d7) was used in flow cytometry on human samples . Retrovirology (2013) ncbi
Articles Reviewed
  1. Fu Y, Ding Y, Wang Q, Zhu F, Tan Y, Lu X, et al. Blood-stage malaria parasites manipulate host innate immune responses through the induction of sFGL2. Sci Adv. 2020;6:eaay9269 pubmed publisher
  2. Burel J, Pomaznoy M, Lindestam Arlehamn C, Weiskopf D, da Silva Antunes R, Jung Y, et al. Circulating T cell-monocyte complexes are markers of immune perturbations. elife. 2019;8: pubmed publisher
  3. McLaren J, Clement M, Marsden M, Miners K, Llewellyn Lacey S, Grant E, et al. IL-33 Augments Virus-Specific Memory T Cell Inflation and Potentiates the Efficacy of an Attenuated Cytomegalovirus-Based Vaccine. J Immunol. 2019;202:943-955 pubmed publisher
  4. Ruscetti M, Leibold J, Bott M, Fennell M, Kulick A, Salgado N, et al. NK cell-mediated cytotoxicity contributes to tumor control by a cytostatic drug combination. Science. 2018;362:1416-1422 pubmed publisher
  5. Obino D, Fetler L, Soza A, Malbec O, Saez J, Labarca M, et al. Galectin-8 Favors the Presentation of Surface-Tethered Antigens by Stabilizing the B Cell Immune Synapse. Cell Rep. 2018;25:3110-3122.e6 pubmed publisher
  6. Perciani C, Farah B, Kaul R, Ostrowski M, Mahmud S, Anzala O, et al. Live attenuated varicella-zoster virus vaccine does not induce HIV target cell activation. J Clin Invest. 2019;129:875-886 pubmed publisher
  7. Muscate F, Stetter N, Schramm C, Schulze zur Wiesch J, Bosurgi L, Jacobs T. HVEM and CD160: Regulators of Immunopathology During Malaria Blood-Stage. Front Immunol. 2018;9:2611 pubmed publisher
  8. Chu J, Mccormick B, Mazelyte G, Michael M, Vermeren S. HoxB8 neutrophils replicate Fcγ receptor and integrin-induced neutrophil signaling and functions. J Leukoc Biol. 2019;105:93-100 pubmed publisher
  9. Armas González E, Domínguez Luis M, Díaz Martín A, Arce Franco M, Castro Hernandez J, Danelon G, et al. Role of CXCL13 and CCL20 in the recruitment of B cells to inflammatory foci in chronic arthritis. Arthritis Res Ther. 2018;20:114 pubmed publisher
  10. Dipiazza A, Laniewski N, Rattan A, Topham D, Miller J, Sant A. CD4 T Cell Epitope Specificity and Cytokine Potential Are Preserved as Cells Transition from the Lung Vasculature to Lung Tissue following Influenza Virus Infection. J Virol. 2018;92: pubmed publisher
  11. Liu H, Dai X, Cao X, Yan H, Ji X, Zhang H, et al. PRDM4 mediates YAP-induced cell invasion by activating leukocyte-specific integrin β2 expression. EMBO Rep. 2018;19: pubmed publisher
  12. Hailemichael Y, Woods A, Fu T, He Q, Nielsen M, Hasan F, et al. Cancer vaccine formulation dictates synergy with CTLA-4 and PD-L1 checkpoint blockade therapy. J Clin Invest. 2018;128:1338-1354 pubmed publisher
  13. Lee C, Zhang H, Singh S, Koo L, Kabat J, Tsang H, et al. C/EBPδ drives interactions between human MAIT cells and endothelial cells that are important for extravasation. elife. 2018;7: pubmed publisher
  14. Wolf D, Anto Michel N, Blankenbach H, Wiedemann A, Buscher K, Hohmann J, et al. A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense. Nat Commun. 2018;9:525 pubmed publisher
  15. Turner D, Goldklang M, Cvetkovski F, Paik D, Trischler J, Barahona J, et al. Biased Generation and In Situ Activation of Lung Tissue-Resident Memory CD4 T Cells in the Pathogenesis of Allergic Asthma. J Immunol. 2018;200:1561-1569 pubmed publisher
  16. Iseka F, Goetz B, Mushtaq I, An W, Cypher L, Bielecki T, et al. Role of the EHD Family of Endocytic Recycling Regulators for TCR Recycling and T Cell Function. J Immunol. 2018;200:483-499 pubmed publisher
  17. Kishore M, Cheung K, Fu H, Bonacina F, Wang G, Coe D, et al. Regulatory T Cell Migration Is Dependent on Glucokinase-Mediated Glycolysis. Immunity. 2017;47:875-889.e10 pubmed publisher
  18. Capece T, Walling B, Lim K, Kim K, Bae S, Chung H, et al. A novel intracellular pool of LFA-1 is critical for asymmetric CD8+ T cell activation and differentiation. J Cell Biol. 2017;216:3817-3829 pubmed publisher
  19. Molnar C, Scherer A, Baraliakos X, de Hooge M, Micheroli R, Exer P, et al. TNF blockers inhibit spinal radiographic progression in ankylosing spondylitis by reducing disease activity: results from the Swiss Clinical Quality Management cohort. Ann Rheum Dis. 2018;77:63-69 pubmed publisher
  20. Cerboni S, Jeremiah N, Gentili M, Gehrmann U, Conrad C, Stolzenberg M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes. J Exp Med. 2017;214:1769-1785 pubmed publisher
  21. Daley D, Mani V, Mohan N, Akkad N, Pandian G, Savadkar S, et al. NLRP3 signaling drives macrophage-induced adaptive immune suppression in pancreatic carcinoma. J Exp Med. 2017;214:1711-1724 pubmed publisher
  22. Chen J, Zhong M, Guo H, Davidson D, Mishel S, Lu Y, et al. SLAMF7 is critical for phagocytosis of haematopoietic tumour cells via Mac-1 integrin. Nature. 2017;544:493-497 pubmed publisher
  23. Deniset J, Surewaard B, Lee W, Kubes P. Splenic Ly6Ghigh mature and Ly6Gint immature neutrophils contribute to eradication of S. pneumoniae. J Exp Med. 2017;214:1333-1350 pubmed publisher
  24. Claser C, de Souza J, Thorburn S, Grau G, Riley E, Renia L, et al. Host Resistance to Plasmodium-Induced Acute Immune Pathology Is Regulated by Interleukin-10 Receptor Signaling. Infect Immun. 2017;85: pubmed publisher
  25. Botting R, Bertram K, Baharlou H, Sandgren K, Fletcher J, Rhodes J, et al. Phenotypic and functional consequences of different isolation protocols on skin mononuclear phagocytes. J Leukoc Biol. 2017;101:1393-1403 pubmed publisher
  26. Hwang I, Kim K, Choi S, Lomunova M. Potentiation of T Cell Stimulatory Activity by Chemical Fixation of a Weak Peptide-MHC Complex. Mol Cells. 2017;40:24-36 pubmed publisher
  27. Rao D, Gurish M, Marshall J, Slowikowski K, Fonseka C, Liu Y, et al. Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis. Nature. 2017;542:110-114 pubmed publisher
  28. Swanson P, Hart G, Russo M, Nayak D, Yazew T, Pena M, et al. CD8+ T Cells Induce Fatal Brainstem Pathology during Cerebral Malaria via Luminal Antigen-Specific Engagement of Brain Vasculature. PLoS Pathog. 2016;12:e1006022 pubmed publisher
  29. Gouwy M, Ruytinx P, Radice E, Claudi F, Van Raemdonck K, Bonecchi R, et al. CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS ONE. 2016;11:e0166006 pubmed publisher
  30. Maharaj K, Que N, Hong F, Huck J, Gill S, Wu S, et al. Exploring the Functional Complementation between Grp94 and Hsp90. PLoS ONE. 2016;11:e0166271 pubmed publisher
  31. Murugesan S, Hong J, Yi J, Li D, Beach J, Shao L, et al. Formin-generated actomyosin arcs propel T cell receptor microcluster movement at the immune synapse. J Cell Biol. 2016;215:383-399 pubmed
  32. Yeap W, Wong K, Shimasaki N, Teo E, Quek J, Yong H, et al. CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes. Sci Rep. 2016;6:34310 pubmed publisher
  33. Lewis G, Wehrens E, Labarta Bajo L, Streeck H, Zuniga E. TGF-? receptor maintains CD4 T helper cell identity during chronic viral infections. J Clin Invest. 2016;126:3799-3813 pubmed publisher
  34. Ushiki T, Huntington N, Glaser S, Kiu H, Georgiou A, Zhang J, et al. Rapid Inflammation in Mice Lacking Both SOCS1 and SOCS3 in Hematopoietic Cells. PLoS ONE. 2016;11:e0162111 pubmed publisher
  35. Guo H, Cranert S, Lu Y, Zhong M, Zhang S, Chen J, et al. Deletion of Slam locus in mice reveals inhibitory role of SLAM family in NK cell responses regulated by cytokines and LFA-1. J Exp Med. 2016;213:2187-207 pubmed publisher
  36. Hwang S, Cobb D, Bhadra R, Youngblood B, Khan I. Blimp-1-mediated CD4 T cell exhaustion causes CD8 T cell dysfunction during chronic toxoplasmosis. J Exp Med. 2016;213:1799-818 pubmed publisher
  37. Hashimoto Tane A, Sakuma M, Ike H, Yokosuka T, Kimura Y, Ohara O, et al. Micro-adhesion rings surrounding TCR microclusters are essential for T cell activation. J Exp Med. 2016;213:1609-25 pubmed publisher
  38. Rudolph H, Klopstein A, Gruber I, Blatti C, Lyck R, Engelhardt B. Postarrest stalling rather than crawling favors CD8(+) over CD4(+) T-cell migration across the blood-brain barrier under flow in vitro. Eur J Immunol. 2016;46:2187-203 pubmed publisher
  39. Brinkman C, Iwami D, Hritzo M, Xiong Y, Ahmad S, Simon T, et al. Treg engage lymphotoxin beta receptor for afferent lymphatic transendothelial migration. Nat Commun. 2016;7:12021 pubmed publisher
  40. Li W, Liu L, Gomez A, Zhang J, Ramadan A, Zhang Q, et al. Proteomics analysis reveals a Th17-prone cell population in presymptomatic graft-versus-host disease. JCI Insight. 2016;1: pubmed publisher
  41. Kawamoto E, Okamoto T, Takagi Y, Honda G, Suzuki K, Imai H, et al. LFA-1 and Mac-1 integrins bind to the serine/threonine-rich domain of thrombomodulin. Biochem Biophys Res Commun. 2016;473:1005-1012 pubmed publisher
  42. Xiong Y, Ahmad S, Iwami D, Brinkman C, Bromberg J. T-bet Regulates Natural Regulatory T Cell Afferent Lymphatic Migration and Suppressive Function. J Immunol. 2016;196:2526-40 pubmed publisher
  43. Chen J, Miyanishi M, Wang S, Yamazaki S, Sinha R, Kao K, et al. Hoxb5 marks long-term haematopoietic stem cells and reveals a homogenous perivascular niche. Nature. 2016;530:223-7 pubmed publisher
  44. Ludigs K, Jandus C, Utzschneider D, Staehli F, Bessoles S, Dang A, et al. NLRC5 shields T lymphocytes from NK-cell-mediated elimination under inflammatory conditions. Nat Commun. 2016;7:10554 pubmed publisher
  45. Ensan S, Li A, Besla R, Degousee N, Cosme J, Roufaiel M, et al. Self-renewing resident arterial macrophages arise from embryonic CX3CR1(+) precursors and circulating monocytes immediately after birth. Nat Immunol. 2016;17:159-68 pubmed publisher
  46. Moretto M, Khan I. IL-21 Is Important for Induction of KLRG1+ Effector CD8 T Cells during Acute Intracellular Infection. J Immunol. 2016;196:375-84 pubmed publisher
  47. Zhang Z, Wu N, Lu Y, Davidson D, Colonna M, Veillette A. DNAM-1 controls NK cell activation via an ITT-like motif. J Exp Med. 2015;212:2165-82 pubmed publisher
  48. Arriola Apelo S, Neuman J, Baar E, Syed F, Cummings N, Brar H, et al. Alternative rapamycin treatment regimens mitigate the impact of rapamycin on glucose homeostasis and the immune system. Aging Cell. 2016;15:28-38 pubmed publisher
  49. Mikucki M, Fisher D, Matsuzaki J, Skitzki J, Gaulin N, Muhitch J, et al. Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints. Nat Commun. 2015;6:7458 pubmed publisher
  50. Yoshida Y, Shimizu I, Katsuumi G, Jiao S, Suda M, Hayashi Y, et al. p53-Induced inflammation exacerbates cardiac dysfunction during pressure overload. J Mol Cell Cardiol. 2015;85:183-98 pubmed publisher
  51. McArthur M, Fresnay S, Magder L, Darton T, Jones C, Waddington C, et al. Activation of Salmonella Typhi-specific regulatory T cells in typhoid disease in a wild-type S. Typhi challenge model. PLoS Pathog. 2015;11:e1004914 pubmed publisher
  52. Wang H, Hong L, Huang J, Jiang Q, Tao R, Tan C, et al. P2RX7 sensitizes Mac-1/ICAM-1-dependent leukocyte-endothelial adhesion and promotes neurovascular injury during septic encephalopathy. Cell Res. 2015;25:674-90 pubmed publisher
  53. DaFonseca S, Niessl J, Pouvreau S, Wacleche V, Gosselin A, Cleret Buhot A, et al. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART. Retrovirology. 2015;12:38 pubmed publisher
  54. Funakoshi S, Shimizu T, Numata O, Ato M, Melchers F, Ohnishi K. BILL-cadherin/cadherin-17 contributes to the survival of memory B cells. PLoS ONE. 2015;10:e0117566 pubmed publisher
  55. Cabrera Perez J, Condotta S, James B, Kashem S, Brincks E, Rai D, et al. Alterations in antigen-specific naive CD4 T cell precursors after sepsis impairs their responsiveness to pathogen challenge. J Immunol. 2015;194:1609-20 pubmed publisher
  56. Glatigny S, Duhen R, Arbelaez C, Kumari S, Bettelli E. Integrin alpha L controls the homing of regulatory T cells during CNS autoimmunity in the absence of integrin alpha 4. Sci Rep. 2015;5:7834 pubmed publisher
  57. Spada R, Rojas J, Pérez Yagüe S, Mulens V, Cannata Ortiz P, Bragado R, et al. NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery. J Leukoc Biol. 2015;97:583-98 pubmed publisher
  58. Shindo Y, Unsinger J, Burnham C, Green J, Hotchkiss R. Interleukin-7 and anti-programmed cell death 1 antibody have differing effects to reverse sepsis-induced immunosuppression. Shock. 2015;43:334-43 pubmed publisher
  59. Ueno N, Lodoen M, Hickey G, Robey E, Coombes J. Toxoplasma gondii-infected natural killer cells display a hypermotility phenotype in vivo. Immunol Cell Biol. 2015;93:508-13 pubmed publisher
  60. Edwards C, Best S, Gun S, Claser C, James K, de Oca M, et al. Spatiotemporal requirements for IRF7 in mediating type I IFN-dependent susceptibility to blood-stage Plasmodium infection. Eur J Immunol. 2015;45:130-41 pubmed publisher
  61. Lin W, Fan Z, Suo Y, Deng Y, Zhang M, Wang J, et al. The bullseye synapse formed between CD4+ T-cell and staphylococcal enterotoxin B-pulsed dendritic cell is a suppressive synapse in T-cell response. Immunol Cell Biol. 2015;93:99-110 pubmed publisher
  62. Davey M, Morgan M, Liuzzi A, Tyler C, Khan M, Szakmany T, et al. Microbe-specific unconventional T cells induce human neutrophil differentiation into antigen cross-presenting cells. J Immunol. 2014;193:3704-3716 pubmed publisher
  63. Verhagen J, Wraith D. Blockade of LFA-1 augments in vitro differentiation of antigen-induced Foxp3? Treg cells. J Immunol Methods. 2014;414:58-64 pubmed publisher
  64. Breuer J, Schwab N, Schneider Hohendorf T, Marziniak M, Mohan H, Bhatia U, et al. Ultraviolet B light attenuates the systemic immune response in central nervous system autoimmunity. Ann Neurol. 2014;75:739-58 pubmed publisher
  65. Dupont C, Christian D, Selleck E, Pepper M, Leney Greene M, Harms Pritchard G, et al. Parasite fate and involvement of infected cells in the induction of CD4+ and CD8+ T cell responses to Toxoplasma gondii. PLoS Pathog. 2014;10:e1004047 pubmed publisher
  66. Fu H, Kishore M, Gittens B, Wang G, Coe D, Komarowska I, et al. Self-recognition of the endothelium enables regulatory T-cell trafficking and defines the kinetics of immune regulation. Nat Commun. 2014;5:3436 pubmed publisher
  67. Weckbach L, Gola A, Winkelmann M, Jakob S, Groesser L, Borgolte J, et al. The cytokine midkine supports neutrophil trafficking during acute inflammation by promoting adhesion via ?2 integrins (CD11/CD18). Blood. 2014;123:1887-96 pubmed publisher
  68. Misumi I, Whitmire J. B cell depletion curtails CD4+ T cell memory and reduces protection against disseminating virus infection. J Immunol. 2014;192:1597-608 pubmed publisher
  69. Krishnan S, Wilson E, Sheikh V, Rupert A, Mendoza D, Yang J, et al. Evidence for innate immune system activation in HIV type 1-infected elite controllers. J Infect Dis. 2014;209:931-9 pubmed publisher
  70. Tuli A, Thiery J, James A, Michelet X, Sharma M, Garg S, et al. Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity. Mol Biol Cell. 2013;24:3721-35 pubmed publisher
  71. Li H, Pauza C. Critical roles for Akt kinase in controlling HIV envelope-mediated depletion of CD4 T cells. Retrovirology. 2013;10:60 pubmed publisher
  72. King S, Knorn A, Ohnmacht C, Voehringer D. Accumulation of effector CD4 T cells during type 2 immune responses is negatively regulated by Stat6. J Immunol. 2008;180:754-63 pubmed
  73. Hamdy S, Elamanchili P, Alshamsan A, Molavi O, Satou T, Samuel J. Enhanced antigen-specific primary CD4+ and CD8+ responses by codelivery of ovalbumin and toll-like receptor ligand monophosphoryl lipid A in poly(D,L-lactic-co-glycolic acid) nanoparticles. J Biomed Mater Res A. 2007;81:652-62 pubmed